Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Revenue

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. had revenue of 260.48M CNY in the quarter ending June 30, 2024, a decrease of -21.94%. This brings the company's revenue in the last twelve months to 736.03M, down -42.62% year-over-year. In the year 2023, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. had annual revenue of 850.73M, down -17.50%.

• Revenue (ttm): 736.03M CNY
• Revenue Growth: -42.62%
• P/S Ratio: 3.70
• Revenue / Employee: 776.40K CNY
• Employees: 948
• Market Cap: 7.82B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	850.73M	-180.43M	-17.50%
Dec 31, 2022	1.03B	-109.15M	-9.57%
Dec 31, 2021	1.14B	306.51M	36.76%
Dec 31, 2020	833.80M	-195.49M	-18.99%
Dec 31, 2019	1.03B	287.45M	38.75%